4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-23-043278
Options or other derivatives
- Chief Medical Officer acquired 82,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levisetti Matteo Chief Medical Officer | 2023-07-21 | Grant or award · Stock Option (right to buy) | +82,500 | 82,500 | D: show line 1 in the form |
Loading xslF345X05/doc4.xml…